KBC Group’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$211K Buy
7,067
+1,465
+26% +$45K ﹤0.01% 994
2026
Q2
$194K Hold
5,602
– – ﹤0.01% 1059
2026
Q1
$116K Hold
5,602
– – ﹤0.01% 1240
2025
Q4
$182K Hold
5,602
– – ﹤0.01% 950
2025
Q3
$318K Buy
5,602
+661
+13% +$33.9K ﹤0.01% 765
2025
Q2
$246K Sell
4,941
-3,487
-41% -$158K ﹤0.01% 798
2025
Q1
$249K Sell
8,428
-43
-0.5% -$1.6K ﹤0.01% 949
2024
Q4
$205K Buy
8,471
+4,396
+108% +$109K ﹤0.01% 1116
2024
Q3
$75K Hold
4,075
– – ﹤0.01% 1477
2024
Q2
$82K Buy
+4,075
New +$67.8K ﹤0.01% 1291

Other funds holding HIMS

KBC Group's HIMS Position: Q3 2026 in Review

KBC Group increased its Hims & Hers Health (HIMS) stake by 26% in Q3 2026, buying an estimated $45K and bringing the position to 7,067 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #994.

KBC Group first reported a position in HIMS in Q2 2024 and has held it in 10 quarters since. The position peaked at $318K in Q3 2025. 378 funds tracked by Wall St. Rank hold HIMS as of Q3 2026.

  • KBC Group held 7,067 shares of Hims & Hers Health worth $211K as of Q3 2026.
  • KBC Group bought 1,465 Hims & Hers Health shares in Q3 2026, an estimated $45K.
  • Hims & Hers Health made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #994 holding.
  • KBC Group first reported a position in Hims & Hers Health in Q2 2024 and has held it in 10 quarters since.
  • KBC Group's Hims & Hers Health position peaked at $318K in Q3 2025.
  • 378 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.